Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabis epilepsy:

Search results

Items: 1 to 20 of 202

1.

Therapeutic Use of medicinal cannabis in difficult to manage epilepsy.

Lawson JA, Scheffer IE.

Br J Clin Pharmacol. 2018 Aug 7. doi: 10.1111/bcp.13711. [Epub ahead of print] Review. No abstract available.

PMID:
30088286
2.

Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.

Suraev A, Lintzeris N, Stuart J, Kevin RC, Blackburn R, Richards E, Arnold JC, Ireland C, Todd L, Allsop DJ, McGregor IS.

Sci Rep. 2018 Aug 2;8(1):11850. doi: 10.1038/s41598-018-30164-8.

3.

Overlaps in pharmacology for the treatment of chronic pain and mental health disorders.

Sutherland AM, Nicholls J, Bao J, Clarke H.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 25. pii: S0278-5846(17)30382-2. doi: 10.1016/j.pnpbp.2018.07.017. [Epub ahead of print] Review.

PMID:
30055217
4.

Cannabis for pediatric epilepsy: protocol for a living systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter B, Skidmore B, Alexander C, Repetski AE, McCoy B, Wells GA.

Syst Rev. 2018 Jul 18;7(1):95. doi: 10.1186/s13643-018-0761-2.

5.

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.

Reithmeier D, Tang-Wai R, Seifert B, Lyon AW, Alcorn J, Acton B, Corley S, Prosser-Loose E, Mousseau DD, Lim HJ, Tellez-Zenteno J, Huh L, Leung E, Carmant L, Huntsman RJ.

BMC Pediatr. 2018 Jul 7;18(1):221. doi: 10.1186/s12887-018-1191-y.

6.

Medicinal Cannabis in Pregnancy - Panacea or Noxious Weed?

O'Connor M.

J Law Med. 2018 Apr;25(3):634-646.

PMID:
29978658
7.

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.

Suraev A, Lintzeris N, Stuart J, Kevin RC, Blackburn R, Richards E, Arnold JC, Ireland C, Todd L, Allsop DJ, McGregor IS.

Sci Rep. 2018 Jul 5;8(1):10154. doi: 10.1038/s41598-018-28127-0. Erratum in: Sci Rep. 2018 Aug 2;8(1):11850.

8.

Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey.

Karanges EA, Suraev A, Elias N, Manocha R, McGregor IS.

BMJ Open. 2018 Jul 3;8(7):e022101. doi: 10.1136/bmjopen-2018-022101.

9.

Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases.

Prandi C, Blangetti M, Namdar D, Koltai H.

Molecules. 2018 Jun 25;23(7). pii: E1526. doi: 10.3390/molecules23071526. Review.

10.

Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.

Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SS, Nowierski C, Lamba A, Bhatti U, Szewczuk MR.

Drug Healthc Patient Saf. 2018 Jun 11;10:45-66. doi: 10.2147/DHPS.S158592. eCollection 2018. Review.

11.

Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos.

Valim Brigante TA, Abe FR, Zuardi AW, Hallak JEC, Crippa JAS, de Oliveira DP.

Chem Biol Interact. 2018 Aug 1;291:81-86. doi: 10.1016/j.cbi.2018.06.008. Epub 2018 Jun 11.

PMID:
29902416
12.

Review of the neurological benefits of phytocannabinoids.

Maroon J, Bost J.

Surg Neurol Int. 2018 Apr 26;9:91. doi: 10.4103/sni.sni_45_18. eCollection 2018. Review.

13.

Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.

Hausman-Kedem M, Menascu S, Kramer U.

Brain Dev. 2018 Aug;40(7):544-551. doi: 10.1016/j.braindev.2018.03.013. Epub 2018 Apr 16.

PMID:
29674131
14.

Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy.

Post JM, Loch S, Lerner R, Remmers F, Lomazzo E, Lutz B, Bindila L.

Front Mol Neurosci. 2018 Mar 14;11:67. doi: 10.3389/fnmol.2018.00067. eCollection 2018.

15.

Police probe of Brazilian marijuana researcher sparks protests.

Angelo C.

Nature. 2018 Mar 15;555(7696):296. doi: 10.1038/d41586-018-02842-0. No abstract available.

PMID:
29542710
16.

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.

Stockings E, Zagic D, Campbell G, Weier M, Hall WD, Nielsen S, Herkes GK, Farrell M, Degenhardt L.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):741-753. doi: 10.1136/jnnp-2017-317168. Epub 2018 Mar 6. Review.

PMID:
29511052
17.

Species-specific susceptibility to cannabis-induced convulsions.

Whalley BJ, Lin H, Bell L, Hill T, Patel A, Gray RA, Elizabeth Roberts C, Devinsky O, Bazelot M, Williams CM, Stephens GJ.

Br J Pharmacol. 2018 Feb 19. doi: 10.1111/bph.14165. [Epub ahead of print]

PMID:
29457829
18.

Cannabis for paediatric epilepsy: challenges and conundrums.

Chen KA, Farrar MA, Cardamone M, Lawson JA.

Med J Aust. 2018 Feb 19;208(3):132-136.

PMID:
29438649
19.

Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.

Porcari GS, Fu C, Doll ED, Carter EG, Carson RP.

Epilepsy Behav. 2018 Mar;80:240-246. doi: 10.1016/j.yebeh.2018.01.026. Epub 2018 Feb 9.

20.

The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users.

Batalla A, Lorenzetti V, Chye Y, Yücel M, Soriano-Mas C, Bhattacharyya S, Torrens M, Crippa JAS, Martín-Santos R.

Cannabis Cannabinoid Res. 2018 Feb 1;3(1):1-10. doi: 10.1089/can.2017.0021. eCollection 2018.

Supplemental Content

Loading ...
Support Center